Patent Assignment
Reel/Frame 055842/0289
Assignment of Assignor's Interest
Recorded: 2021-04-06
Pages: 7
Assignors
HUMBERT, OLIVIER
Executed: 2019-12-17
KIEM, HANS-PETER
Executed: 2019-12-17
WALTER, ROLAND B.
Executed: 2019-12-17
Assignee
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Reducing CD33 Expression to Selectively Protect Therapeutic Cells
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name
Jun 24, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060441/0185 →
Confirmatory License
Nov 22, 2023
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065665/0317 →